Prevention of parenteral nutrition-induced gut hypoplasia by coinfusion of glucagon-like peptide-2

被引:127
|
作者
Chance, WT [1 ]
FoleyNelson, T [1 ]
Thomas, I [1 ]
Balasubramaniam, A [1 ]
机构
[1] UNIV CINCINNATI, MED CTR, DEPT SURG, CINCINNATI, OH 45267 USA
关键词
total parenteral nutrition; duodenum; jejunum; ileum; colon; rat; mucosa;
D O I
10.1152/ajpgi.1997.273.2.G559
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Maintaining rats on total parenteral nutrition (TPN) for 6 days significantly reduced mass (-34%), protein (-32%), and DNA (-35%) in small intestine and colon (29-37% decrease). Coinfusion of glucagon-like peptide-2 (GLP-2) normalized each of these variables in duodenum, jejunum, and ileum, but not in colon. Histological analysis of tissue revealed normal mucosa thickness and villus height in small intestine of GLP-2-treated rats, whereas nontreated rats maintained on TPN exhibited villus shortening (-30%) and thinning (-23%) of mucosa. These results suggest that hormonal alterations may be more important than an absence of luminal nutrition in TPN-associated mucosal changes. Additionally, GLP-2 normalization of gut mucosa permits accurate assessment of the influence of reversal of hypoplasia on gut barrier function.
引用
收藏
页码:G559 / G563
页数:5
相关论文
共 50 条
  • [1] The role of polyamines in glucagon-like peptide-2 prevention of TPN-induced gut hypoplasia
    Chance, WT
    Sheriff, S
    Dayal, R
    Friend, LA
    Thomas, I
    Balasubramaniam, A
    PEPTIDES, 2006, 27 (04) : 883 - 892
  • [2] Glucagon-like peptide-2
    Estall, Jennifer L.
    Drucker, Daniel J.
    ANNUAL REVIEW OF NUTRITION, 2006, 26 : 391 - 411
  • [3] Glucagon-like peptide-1 and glucagon-like peptide-2
    Baggio, LL
    Drucker, DJ
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 18 (04) : 531 - 554
  • [4] Glucagon-like peptide-1, glucagon-like peptide-2, and lipid metabolism
    Lutz, Thomas A.
    Osto, Elena
    CURRENT OPINION IN LIPIDOLOGY, 2016, 27 (03) : 257 - 263
  • [5] The dimerization of glucagon-like peptide-2 MIMETIBODY™ is linked to leucine-17 in the glucagon-like peptide-2 region
    E. Baker, Audrey
    Sague, Sarah
    Grygiel, Tami L. R.
    Schmidt, Albert
    Rogers, Alison
    Jiang, Haiyan
    Kruszynski, Marian
    Nesspor, Tom
    JOURNAL OF MOLECULAR RECOGNITION, 2012, 25 (03) : 155 - 164
  • [6] A biological function for glucagon-like peptide-2
    Hussain, MA
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1998, 139 (03) : 265 - 267
  • [7] Glucagon-Like Peptide-2 Alters Bile Acid Metabolism in Parenteral Nutrition-Associated Liver Disease
    Lim, David W.
    Wales, Paul W.
    Mi, Si
    Yap, Jason Y. K.
    Curtis, Jonathan M.
    Mager, Diana R.
    Mazurak, Vera C.
    Wizzard, Pamela R.
    Sigalet, David L.
    Turner, Justine M.
    JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2016, 40 (01) : 22 - 36
  • [8] Glucagon-like peptide-2: gut signal and lipid parameters in obese mice
    Baldassano, S.
    Amato, A.
    Mule, F.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2015, 27 : 41 - 41
  • [9] The alpha cell expresses glucagon-like peptide-2 receptors and glucagon-like peptide-2 stimulates glucagon secretion from the rat pancreas
    de Heer, J.
    Pedersen, J.
    Orskov, C.
    Holst, J. J.
    DIABETOLOGIA, 2007, 50 (10) : 2135 - 2142
  • [10] The alpha cell expresses glucagon-like peptide-2 receptors and glucagon-like peptide-2 stimulates glucagon secretion from the rat pancreas
    J. de Heer
    J. Pedersen
    C. Ørskov
    J. J. Holst
    Diabetologia, 2007, 50 : 2135 - 2142